Oculis Holding AG has embarked on a pioneering effort to tackle dry eye disease using a genotype-based approach. The first patient has been enrolled in the PREDICT-1 registrational trial for Licaminlimab, opening a new chapter in personalized eye care.

China’s top health authority has granted Adcentrx Therapeutics approval to proceed with trials for ADRX-0405, an investigational STEAP1 antibody-drug conjugate aiming to treat late-stage solid tumors, including prostate cancer. Building on progress from its U.S. Phase 1a/1b study, the company aims to broaden the trial’s reach and accelerate patient enrollment by including clinical centers in China.

Summer break can disrupt daily routines, leading to surges in anxiety, loneliness, and increased screen time among children and parents. This often-overlooked issue highlights the mental health challenges families may encounter during these months.

Eledon Pharmaceuticals has released updated findings from an investigator-initiated islet transplant trial at UChicago Medicine, focusing on the potential of Tegoprubart in treating Type 1 Diabetes. The new data marks a key step forward for transplant-based research in diabetes care.

Upstream Bio is set to deliver additional clinical findings from its Phase 2 VIBRANT trial of verekitug, aimed at treating chronic rhinosinusitis with nasal polyps. The data, which centers on a responder analysis, will be presented at the EAACI 2026 Congress in Istanbul on June 14, 2026.

Travelers are increasingly seeking ayahuasca retreats in remote corners of Mexico and the Peruvian Amazon, guided by spiritual experts with ties to centuries-old traditions. These ceremonies emphasize mental health, personal insight, and wellness, providing an experience that blends cultural reverence and modern self-care.

Two readers wrote in to “Dear Abby,” detailing one boss’s intrusive fiancé and one looming pregnancy for a 40-year-old mother. Both stories highlight the deep anxieties caused by unclear boundaries, unwanted conflict, and the urgent need for open, honest communication.

Service workers in a busy valley are bracing for the rush of summer tourism, marking the close of a short reprieve. The article suggests stocking up on prescriptions and mental health essentials, as the season’s demands loom large on the horizon.

A high-risk multiple myeloma diagnosis transformed one patient’s life in December 2020. Now enrolled in a Phase 2 clinical trial, they continue to experience persistent numbness even after four years of treatment.

A new report by the Trevor Project shows that one in 10 LGBTQ+ young people attempted suicide last year, and more than a third considered taking their own lives. Advocates say these numbers underscore the need to restore a hotline specifically tailored to LGBTQ+ youth in crisis.

Three times a year, one parent is back in court battling an ex over custody issues. While the costs mount into the thousands, the court’s most recent order requires both parties to attend co-parenting classes—raising questions about whether lasting change is truly possible.

Savara (Nasdaq: SVRA) has released encouraging long-term Phase 3 data suggesting that patients receiving molgramostim for an autoimmune pulmonary condition continue to see improved lung function and respiratory health. Announced in Langhorne, Pennsylvania, the results spotlight a potential breakthrough for individuals affected by persistent breathing challenges.

Halligan the Dalmatian is offering more than just a friendly face in Searsmont, Maine—he’s providing comfort and support to firefighters in need. Guided by his handler, former first responder Timothy Nickels, Halligan represents a new model of emotional care on the front lines.

Repeatedly missing salon appointments has left one woman feeling embarrassed and worried about her relationship with her hairstylist. As her memory lapses pile up, she struggles to address the resulting strain with no clear solution.

In the aftermath of the Lahaina wildfires, a Detox & Wellness Workshop aims to support community-wide healing. Held at the Lahaina Jodo Mission on June 6, the event highlights holistic methods to help residents recover and reconnect.

For years, these two sisters were inseparable, sharing everything from clothes to private jokes. Now, one writes about the distance that has crept in and her longing to rekindle their former closeness. This short plea highlights the fragility of sibling ties and the enduring hope for reconciliation.

A new report highlights more than 75 drugs under consideration for Duchenne muscular dystrophy, promising significant progress in patient care. The analysis explores clinical strategies, upcoming therapies, and commercial prospects, signaling a major shift in the DMD landscape.

Two of Climb Bio’s most promising therapies—CLYM116 and budoprutug—will be in the spotlight at the European Renal Association Congress 2026. The company is sharing early safety data and a Phase 2 trial update in Glasgow, Scotland, detailing its mission to advance treatment options for immune-mediated kidney diseases.

After battling alcohol abuse for ten years, a veteran decided that relying on a friend’s support alone was not enough. He found renewed hope in a VA program that helped him move forward on the path to lasting recovery.

A recent Dear Abby column highlights a dilemma many families face: how to handle a disruptive sibling while preserving long-held family ties. One reader’s wish to keep the peace underscores the complex responsibilities that often accompany familial relationships.

Groundbreaking news from Immusoft reveals the treatment of the world’s first patient with a B cell-based therapy. With support from the FDA and ARM, the company showcases a next-generation approach focusing on scalability and re-dosability.